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acrophage death in advanced atherosclerosis
promotes necrosis and plaque destabilization.
A likely cause of macrophage death is accu-
mulation of free cholesterol (FC) in the ER, leading to
activation of the unfolded protein response (UPR) and
C/EBP homologous protein (CHOP)–induced apoptosis.
Here we show that p38 MAPK signaling is necessary for
CHOP induction and apoptosis. Additionally, two other
signaling pathways must cooperate with p38-CHOP to
effect apoptosis. One involves the type A scavenger re-
ceptor (SRA). As evidence, FC loading by non-SRA
M
 
mechanisms activates p38 and CHOP, but not apoptosis
unless the SRA is engaged. The other pathway involves
c-Jun NH
 
2
 
-terminal kinase (JNK)2, which is activated by
cholesterol trafﬁcking to the ER, but is independent of
CHOP. Thus, FC-induced apoptosis requires cholesterol
trafﬁcking to the ER, which triggers p38-CHOP and
JNK2, and engagement of the SRA. These ﬁndings have
important implications for understanding how the UPR,
MAPKs, and the SRA might conspire to cause macro-
phage death, lesional necrosis, and plaque destabilization
in advanced atherosclerotic lesions.
 
Introduction
 
Macrophage death in advanced atherosclerotic lesions promotes
lesional necrosis, which, in turn, is associated with plaque
instability and acute atherothrombotic vasculature occlusion
(Ball et al., 1995; Ross, 1995; Libby et al., 1996; Mitchinson et
al., 1996; Kolodgie et al., 2000; Feng et al., 2003b). One of the
postulated causes of macrophage death in advanced lesions is
intracellular accumulation of unesterified, or “free,” cholesterol
(FC) (Lupu et al., 1987; Tabas, 2002; Feng et al., 2003b).
Whereas macrophages in early lesions store most lipoprotein-
derived cholesterol in the esterified form because of the ac-
tion of acyl-coenzyme A-cholesterol acyltransferase (ACAT),
macrophages in late lesions accumulate increasing amounts of
FC, probably as the result of combined deficiencies of ACAT
activity and cholesterol efflux (Tabas, 2002). In various cell
culture models, which use macrophages incubated with acety-
lated low-density lipoprotein (ac-LDL) under conditions of de-
ficient ACAT activity, FC accumulates and induces apoptosis
(Kellner-Weibel et al., 1998; Yao and Tabas, 2000, 2001). Ac-
LDL is a model lipoprotein that, like various types of athero-
genic lipoproteins in atherosclerotic lesions, enters macro-
phages by way of the type A scavenger receptor (SRA) (Hen-
riksen et al., 1981; Brown and Goldstein, 1985). In this model,
mitochondrial- and Fas-dependent pathways of apoptosis are in-
duced as measured by caspase activation, loss of mitochondrial
membrane potential, and increased TUNEL staining (Yao and
Tabas, 2000, 2001).
We recently showed that FC trafficking to the ER triggers
the unfolded protein response (UPR) (Feng et al., 2003a). FC
enrichment of the normally cholesterol-poor and fluid ER
membrane causes an increase in order parameter, or packing,
of the membrane phospholipids. Stiffening of the ER mem-
brane by this process is associated with the dysfunction of a
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particular integral membrane protein, sarcoendoplasmic re-
ticulum ATPase, and it is likely that other ER membrane
proteins are adversely affected (Li et al., 2004). These events
almost certainly contribute to the induction of the UPR. Most im-
portantly, FC trafficking to the ER and activation of the C/EBP
homologous protein (CHOP) branch of the UPR are required
for a significant portion of FC-induced apoptosis (Feng et al.,
2003a). Moreover, in vivo studies support the relevance of this
model to macrophage apoptosis and lesional necrosis in ad-
vanced atherosclerotic lesions (Feng et al., 2003b).
In ongoing studies in the laboratory, we found that FC
loading of macrophages activates the p38 MAPK and c-Jun
NH
 
2
 
-terminal kinase (JNK) pathways (Li et al., 2005). In view
of this finding and previous literature suggesting possible links
between MAPK activation and the UPR and apoptosis (Wang
et al., 1996; Maytin et al., 2001; Matsuzawa et al., 2002;
Yamamoto et al., 2003; Li and Holbrook, 2004), we sought to
determine whether p38 and/or JNK activation played a role in
these processes in FC-loaded macrophages. We found that the
MAP kinase kinase 3–p38 (MKK3-p38) pathway, but not the
JNK pathway, is necessary for CHOP induction. However, p38
and JNK are necessary for apoptosis in our model of FC-
induced macrophage death. Most importantly, we discovered
that MAPK and UPR activation are not sufficient to trigger
apoptosis without another “hit,” namely engagement
 
 
 
SRA. We
found that SRA-mediated triggering of apoptosis is not unique
to FC loading, and can serve as a general trigger for apoptosis
in ER-stressed cells. These data provide evidence for a “multi-
ple hit” paradigm that is related to how ER stress can lead to
cellular apoptosis, and suggest a novel role for the SRA and
MAPKs in macrophage death, lesional necrosis, and plaque
disruption in advanced atherosclerotic lesions.
 
Results
 
MKK3/p38 MAPK activation is 
necessary for CHOP induction in 
cholesterol-enriched macrophages
 
Ongoing work in our laboratory has revealed that p38 MAPK
is phosphorylated and activated in the early, preapoptotic
stages of FC loading. p38 activation is downstream of MKK3
as indicated by the absence of p38 phosphorylation in FC-
loaded macrophages from 
 
Mkk3
 
 
 
/
 
 
 
 mice (Fig. 1 A and Li et
al., 2005). Because the commonly used p38 pathway inhibi-
tors (e.g., SB203580) are inhibitors of cholesterol trafficking
(unpublished data), 
 
Mkk3
 
-deficient macrophages are an es-
sential tool to determine the consequences of FC-induced
p38 activation.
In this context, we tested whether the MKK3-p38 path-
way was necessary for induction of the UPR effector, CHOP,
in macrophages that were loaded with FC by the standard
protocol (incubation with ac-LDL plus an ACAT inhibitor
[58035]). As shown in Fig. 1 A (top
 
 
 
panel), CHOP was induced
markedly after 10 h of FC loading in macrophages from wild-
type (WT) mice, but not in macrophages from 
 
Mkk3
 
 
 
/
 
 
 
 mice.
Fig. 1 A (middle panel) shows that p38 was phosphorylated
early in the course of FC loading in WT, but not in 
 
Mkk3
 
 
 
/
 
 
 
-
deficient, macrophages. As expected, p38 phosphorylation cor-
related with p38 activation, as determined by in vitro phosphor-
ylation of the p38 substrate, ATF-2 (unpublished data). Note
that p38 phosphorylation showed a biphasic, pattern: moderate
expression 2–5 h after FC loading, then a decrease between
5–10 h, followed by an increase by 15 h. In contrast, CHOP
expression first became substantial at 10 h after FC loading,
and persisted to the 15-h time point. As a control, the blot was
reprobed for total p38, which did not change substantially un-
der any of the conditions (Fig. 1 A, bottom panel). These data
Figure 1. Activation of Mkk3/p38 MAPK is necessary for CHOP induction
in FC-loaded macrophages. (A) WT and Mkk3
 /  macrophages (M s)
were FC-loaded for 0, 2, 5, 7, 10, and 15 h using 100  g/ml ac-LDL plus
the ACAT inhibitor 58035. Whole cell lysates were prepared as de-
scribed under “Materials and methods” and immunoblotted for CHOP (top
panel), activated phospho-Thr
180/Tyr
182 p38 MAPK (phospho-p38, mid-
dle panel), and total p38 (bottom panel). Lines indicate areas of the same
gel that were spliced together. (B) WT and Chop
 /  macrophages were
left untreated ( ) or were FC-loaded ( ) for 5 h, and lysates were immuno-
blotted for phospho-p38 and total p38. (C) WT and Mkk3
 /  macrophages
were left untreated ( ) or were FC-loaded for 7 h ( ). In some experiments,
WT cells were treated with ac-LDL alone, which showed only minimal
MK2 phosphorylation (not depicted). Whole cell lysates were immunoblot-
ted for activated phospho-Thr
334 MK2 (phospho-MK2, top panel) and total
MK2 (bottom panel). (D) WT and Mk2
 /  macrophages were left un-
treated ( ) or were FC-loaded for 7 h ( ). Whole cell lysates were immuno-
blotted for CHOP (top panel), total MK2 (second panel), total p38 (third
panel), or tubulin as a loading control (bottom panel). Lines indicate areas
of the same gel that were spliced together. 
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are consistent with the MKK3-p38 pathway being upstream of
CHOP induction. This point is supported further by the data in
Fig. 1 B, which show similar p38 phosphorylation in FC-
loaded WT and 
 
Chop
 
 
 
/
 
 
 
 macrophages.
Several downstream targets of p38 have been identified,
such as mitogen-activated protein kinase–activated protein ki-
nase (MK)-2 (Engel et al., 1998; Rane et al., 2001), MK3
(McLaughlin et al., 1996), MK5 (Seternes et al., 2002), and mi-
togen and stress-activated protein kinases 1 and 2 (Deak et al.,
1998). p38 was shown to be directly responsible for phosphor-
ylation and regulation of MK2 activity and localization during
conditions of cell stress, leading to up-regulation of cytokines,
such as TNF
 
 
 
 and interleukin-6 and -1 (Engel et al., 1998;
Ueda et al., 2004). Therefore, we sought to determine if MK2
was activated in response to FC loading. As shown in Fig. 1 C
(top panel), unloaded WT macrophages demonstrated a low
basal level of MK2 phosphorylation, which was increased after
5 h of FC loading. In contrast, the basal level of MK2 phosphor-
ylation in 
 
Mkk3
 
 
 
/
 
 
 
 macrophages was not increased with FC
loading. Note in the bottom blot that both isoforms of total
MK2 remained relatively constant under all conditions. MK2
phosphorylation was much less in cells that were incubated
with ac-LDL alone (unpublished data). In an attempt to deter-
mine the functional importance of MK2 in FC-induced CHOP
expression, we conducted a series of experiments with macro-
phages from 
 
Mk2
 
 
 
/
 
 
 
 mice. CHOP expression was diminished
almost completely in 
 
Mk2
 
 
 
/
 
 
 
-deficient macrophages (Fig. 1 D,
top panel). However, MK2 deficiency also led to loss of p38
protein (Fig. 1 D, third panel), which probably is related to its
ability to stabilize p38 in a positive feedback manner (Kot-
lyarov et al., 2002). Therefore, although these data cannot be
used to demonstrate a direct role of MK2 in CHOP induction,
they provide further evidence for a role of p38.
To determine directly whether p38 was required for CHOP
induction, we repeated these experiments in p38
 
 
 
-deficient
macrophages. The macrophages were obtained from 
 
p38
 
 
 
flox
 
mice that had been crossed with LysMCre mice, which express
Cre recombinase in macrophages (Clausen et al., 1999). As
shown in Fig. S1 (middle panel; available at http://www.jcb.org/
cgi/content/full/jcb.200502078/DC1), p38 was undetectable in
these macrophages. Consistent with the data in Fig. 1, CHOP
induction was diminished markedly in p38
 
 
 
-deficient macro-
phages by FC loading (Fig. S1, top panel). These data further
establish the importance of p38 in CHOP induction of FC-
loaded macrophages.
To determine whether an activator of the p38 pathway,
other than FC loading would induce CHOP expression, we
compared macrophages that were incubated under FC-loading
conditions with those that were incubated with the known
p38 activator, staurosporine (Yamaki et al., 2002). Treatment
with 50 or 100 
 
 
 
M staurosporine for 6 h resulted in strong
p38 activation, which was similar to that observed with 6 h
of FC loading (Fig. 2, first panel). In addition, treatment
with 100 
 
 
 
M staurosporine resulted in MK2 activation that
was similar to that seen with FC loading (Fig. 2, second
panel). However, neither concentration of staurosporine led
to CHOP induction (Fig. 2, third
 
 
 
panel). These data indicate
that activation of the p38/MK2 pathway is not sufficient for
CHOP induction.
Other inducers of the UPR, such as the protein glycosyl-
ation inhibitor, tunicamycin, and the sarcoendoplasmic retic-
ulum calcium ATPase inhibitor, thapsigargin, are known to
activate p38 (Hung et al., 2004; Li and Holbrook, 2004).
Therefore, we questioned whether p38 activation was neces-
sary for CHOP induction by these two UPR inducers. As
shown in Fig. 3 (top panel) p38 was phosphorylated after 5 h
of treatment under FC-loading conditions or with tunicamycin
or thapsigargin in WT macrophages. Phosphorylation of p38
under all three conditions was blocked completely in 
 
Mkk3
 
 
 
/
 
 
 
macrophages. Most importantly, only CHOP induction by FC
loading was blocked by MKK3 deficiency (Fig. 3, third
Figure 2. Staurosporine activates p38 MAPK and MK2, but does not
induce CHOP in macrophages. Macrophages were left untreated ( ), FC
loaded for 6 h ( ) using ac-LDL plus 58035, or treated for 6 h with 50 or
100  M staurosporine. Immunoblot analysis was performed for phospho-
p38 or phospho-MK2 (first and second panels), CHOP (third panel), and
actin (bottom panel).
Figure 3. MKK3-dependent CHOP induction in macrophages is unique to
FC loading. WT and Mkk3
 /  macrophages were left untreated, FC
loaded using ac-LDL plus 58035, or treated with 2.5  g/ml tunicamycin
or 2  M thapsigargin for 7 h. Whole cell lysates were immunoblotted for
phospho-p38 (top panel), total p38 (second panel), CHOP (third panel),
and actin (bottom panel). 
JCB • VOLUME 171 • NUMBER 1 • 2005 64
 
panel). Thus, the requirement for p38 activation in FC-induced
CHOP expression is a unique feature of this particular inducer
of the UPR.
 
Activation of the p38 MAPK/MK2 
pathway is necessary for FC-induced 
apoptosis
 
CHOP is required for apoptosis in macrophages that are loaded
with FC by ac-LDL plus an ACAT inhibitor; MKK3 is required
for the induction of CHOP under these conditions. Therefore, we
hypothesized that the MKK3/p38 pathway is required for FC-
induced apoptosis. As shown in Fig. 4 A, incubation of WT
macrophages with ac-LDL plus 58035 caused a substantial in-
crease in apoptosis, but apoptosis was diminished markedly in
FC-loaded 
 
Mkk3
 
 
 
/
 
 
 
 macrophages. These results cannot be
explained by a decrease in ac-LDL uptake or trafficking of
ac-LDL–derived cholesterol to the ER in 
 
Mkk3
 
 
 
/
 
 
 
 macrophages,
because ac-LDL–induced cholesterol esterification was very
similar between the WT and 
 
Mkk3
 
 
 
/
 
 
 
 macrophages (Fig. 4 B).
Similar results were shown using p38
 
 
 
-deficient (Fig. 4 C) and
 
Mk2
 
 
 
/
 
 
 
 macrophages (Fig. S2; available at http://www.jcb.org/
cgi/content/full/jcb.200502078/DC1). Therefore, activation
of the MKK3/p38 pathway by FC loading of macrophages is
required for CHOP induction and subsequent apoptosis.
Figure 4. The MKK3/p38 MAPK pathway is necessary for FC-induced macrophage apoptosis. WT, Mkk3
 /  (A), and p38 -deficient (C) macrophages
were left untreated or were FC loaded (ac-LDL plus 58035) for 16–18 h. The cells were stained with Alexa 488 Annexin V (green) and propidium iodide
(red). Representative fluorescent images and quantitative apoptosis data from four fields of cells for each condition are shown. The data are expressed as
the percent of total cells that stained with Annexin V and propidium iodide. Data are expressed as mean   SEM (n   4). Bar, 25  m. (B) Esterification of
[
14C] oleate in WT or Mkk3
 /  macrophages incubated 5 h with medium containing [
14C] oleate with or without 100  g/ml ac-LDL. Shown is the
mean   SEM (n   3) of cholesteryl [
14C] oleate cpm per  g of total protein. 
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FC loading of macrophages by CD-
cholesterol induces p38 phosphorylation 
and activates the UPR but does not 
induce apoptosis
 
Previous data from our laboratory showed that loading macro-
phages with cholesterol by a nonlipoprotein route—cholesterol-
saturated methyl-
 
 
 
-cyclodextrin (CD-cholesterol) plus an ACAT
inhibitor—resulted in a similar level of FC mass accumulation as
that observed in macrophages that were loaded by ac-LDL plus
an ACAT inhibitor (Feng et al., 2003a). FC loading by this
method did not induce apoptosis, which we originally believed
was due to poor trafficking of CD-derived cholesterol to the ER
(Feng et al., 2003a). However, subsequent experiments revealed
that cholesterol derived from CD was esterified by ACAT to a
similar degree as lipoprotein-cholesterol, which indicated that the
lack of apoptosis with CD-cholesterol loading required another
explanation. We reasoned that elucidation of this apparent para-
dox could provide important insight into the mechanism of apop-
tosis observed in macrophages loaded with ac-LDL–derived FC.
To begin, we determined whether CD-cholesterol loading
led to p38 phosphorylation and UPR induction. As shown in Fig.
5 A, p38 and MK2 were phosphorylated in CD-cholesterol–
loaded macrophages. Early activation of p38 by CD-cholesterol
(i.e., at 5–8 h) was observed independently of ACAT inhibition.
This finding may be related to a direct effect of CD-derived cho-
lesterol on the plasma membrane; this is in contrast to the situa-
tion with ac-LDL plus the ACAT inhibitor, which involves traf-
ficking of lipoprotein-derived cholesterol to the ER (Li et al.,
2005). However, activation of p38 at 24 h was dependent on
ACAT inhibition, which suggested that this later phase of acti-
vation may be dependent on intracellular cholesterol trafficking.
Most importantly, CD-cholesterol led to induction of CHOP and
phospho-PERK (ds-RNA–activated protein kinase-like ER ki-
nase) by 24 h, indicating activation of the UPR (Fig. 5 B). Given
these data, we considered the possibility that the inability of CD-
cholesterol plus the ACAT inhibitor to induce apoptosis, even at
48 h (unpublished data), was due to the later activation of the
UPR. For example, it is possible that the gradual activation of
the UPR by CD-cholesterol could “precondition” the cells, and
thus, render them resistant to UPR-induced apoptosis, as has
been observed in other systems (Hung et al., 2003), In this re-
gard, we incubated ACAT-inhibited macrophages with 
 
 
 
–very
low density lipoprotein (VLDL), a cholesterol-rich lipoprotein
that is endocytosed rapidly by macrophages. As shown in Fig. 5
C, FC loading using 
 
 
 
-VLDL caused relatively rapid induction
of CHOP and activation of p38, similar to the kinetics using ac-
LDL; however, apoptosis was not induced (Fig. 5 D). CHOP in-
duction by 
 
 
 
-VLDL plus 58035 was diminished in p38
 
 
 
-defi-
cient macrophages (Fig. S3; available at http://www.jcb.org/cgi/
content/full/jcb.200502078/DC1), which demonstrated its de-
pendence on p38 signaling. Thus, even rapid activation of
CHOP and p38 is unable to induce apoptosis when a lipoprotein
other than ac-LDL is used. Therefore, we considered an al-
ternative hypothesis—that FC-induced p38/UPR activation is
necessary, but not sufficient, for apoptosis, and apoptosis of
UPR-activated macrophages requires another “hit” effected by
ac-LDL, but not by CD-cholesterol or 
 
 
 
-VLDL.
Figure 5. FC loading using CD-cholesterol or  -VLDL induces p38
MAPK phosphorylation and UPR induction. (A) Macrophages were left
untreated for 5 h or were incubated with CD-cholesterol (CD-Chol)  
58035 for the indicated number of hours. Whole cell lysate was immuno-
blotted  for phospho-p38, phospho-MK2, and actin. (B) Macrophages
were left untreated or incubated with CD-cholesterol plus 58035 for 8
and 24 h. Nuclear extracts were isolated as described in “Materials and
methods” and were subjected to immunoblot analysis for CHOP and nu-
cleoplasmin (as a loading control). Cytosolic extracts were immunoblot-
ted for phospho-Thr
980 PERK and actin. (C) Macrophages were incu-
bated with CD-cholesterol or 50  g/ml   -VLDL plus 58035 for the
indicated number of hours. Whole cell lysates were subjected to immu-
noblot analysis for CHOP, phospho-p38, and actin. (D) Macrophages
were incubated with 50  g/ml  -VLDL or 100  g/ml ac-LDL plus 58035
for 24 h and then stained with Alexa 488 Annexin V (green) and propid-
ium iodide (red). Bar, 25  m.JCB • VOLUME 171 • NUMBER 1 • 2005 66
SRA engagement induces apoptosis in 
FC-enriched and UPR-activated 
macrophages
One of the differences between ac-LDL and CD-cholesterol or
 -VLDL is that only ac-LDL is a ligand for the SRA (Gold-
stein et al., 1979). Thus, ac-LDL might trigger apoptosis be-
cause it delivers cholesterol and engages the SRA, whereas
CD-cholesterol and  -VLDL only affect the cholesterol load-
ing step. To test this idea, we determined whether apoptosis
could be “reconstituted” by incubating macrophages with a
CD-cholesterol (or  -VLDL) plus a noncholesterol-containing
ligand for the SRA. As shown in Fig. 6 A, neither fucoidan, a
ligand for the SRA, nor CD-cholesterol, induced a substantial
degree of apoptosis when the reagents were added individually.
However, the combination of reagents caused a marked apop-
totic response. The data in Fig. 6 B show similar results with
another SRA ligand, carboxymethyllysine-BSA (CML-BSA),
that has possible relevance to diabetic macrovascular disease.
CML-BSA is an advance glycation end-product (AGE) that
may be formed during the oxidation of lipoproteins in the vas-
cular wall (Fu et al., 1996; Miyazaki et al., 2002). In addition,
the same results were obtained when the source of non-SRA
cholesterol was  -VLDL, instead of CD-cholesterol (Fig. 6 C).
To assess the relationship of CD-cholesterol/fucoidan-induced
apoptosis with ac-LDL–induced apoptosis further, we tested
dependency on the MKK3/p38 MAPK pathway. As shown in
Fig. 6 D, CD-cholesterol/fucoidan-induced apoptosis, like ac-
LDL–induced apoptosis, was decreased markedly in Mkk3
 / 
macrophages; similar results were found in Mk2
 /  macro-
phages (not depicted).
Figure 6. SRA ligands induce apoptosis in
macrophages that are FC loaded by non-SRA
sources of cholesterol, or treated with low-
dose thapsigargin. (A) Macrophages were left
untreated or incubated with 25  g/ml fu-
coidan alone (Fuc), CD-cholesterol plus
58035 alone (CD-Chol), or CD-cholesterol/
58035 plus fucoidan for 24 h. The cells were
stained with Alexa 488 Annexin V (green)
and propidium iodide (red). Representative
fluorescent and bright field images are shown.
Quantitative apoptosis data for each condi-
tion are shown as described in the legend for
Fig. 4. Data are expressed as mean   SEM
(n   8). Bar, 25  m. (B) The experiment was
conducted as in (A) except the macrophages
were incubated for 24 h with 100  g/ml of
CML-BSA, CD-cholesterol/58035, or CD-cho-
lesterol/58035 plus CML-BSA. Bar, 25  m.
As a control, FC-loaded macrophages also
were treated with nonmodified BSA, which
did not induce apoptosis (not depicted). (C)
Quantitative apoptosis data for macrophages
left untreated or incubated for 24 h with 50
 g/ml   -VLDL plus 58035,  -VLDL plus
58035 plus fucoidan (25  g/ml), or 100
 g/ml ac-LDL plus 58035. Data are ex-
pressed as mean   SEM (n   8). (D) Quanti-
tative apoptosis data for WT or Mkk3
 / 
macrophages left untreated or incubated for
24 h with CD-cholesterol/58035 or CD-cho-
lesterol/58035 plus fucoidan. Cells were
stained with Alexa 488 Annexin V and pro-
pidium iodide. Representative quantitative
apoptosis data are from four fields of cells un-
der each condition. Data are expressed as
mean   SEM (n   4). (E) Quantitative apopto-
sis data for macrophages left untreated or in-
cubated for 24 h with fucoidan (25  g/ml),
0.5   M thapsigargin (Tg), or fucoidan plus
thapsigargin. Data are expressed as mean  
SEM (n   8). Representative fluorescent and
bright field images are shown. Bar, 25  m.SRA AND MACROPHAGE APOPTOSIS • DEVRIES-SEIMON ET AL. 67
We next tested whether fucoidan could induce apoptosis in
macrophages in which UPR activation was effected by means
other than cholesterol. For this purpose, macrophages were incu-
bated with thapsigargin in the absence or presence of fucoidan.
Thapsigargin is an inhibitor of sarcoendoplasmic reticulum
ATPase and is an inducer of the UPR (Wong et al., 1993; Berto-
lotti et al., 2000). As shown in Fig. 6 E, 0.5  M thapsigargin
alone and fucoidan alone caused very little apoptosis, but the
combination of these two reagents led to a marked increase in
macrophage apoptosis. Therefore, the ability of fucoidan to trig-
ger apoptosis in UPR-activated cells does not depend upon cho-
lesterol-loading per se. In this context, we also showed that the
ability of fucoidan to trigger apoptosis in UPR-activated cells
was dependent on CHOP; apoptosis induced by  -VLDL/58035
plus fucoidan or by thapsigargin plus fucoidan was blocked al-
most completely in Chop
 /  macrophages (Fig. S4; available at
http://www.jcb.org/cgi/content/full/jcb.200502078/DC1).
Neither fucoidan nor CML-BSA is specific for the SRA
(Bucciarelli et al., 2002). Therefore, it was necessary to deter-
mine if the apoptosis-triggering effect of these molecules was
dependent on the SRA. As shown in Fig. 7, CD-cholesterol/fu-
coidan–induced apoptosis was diminished markedly in Sra
 / 
macrophages. Apoptosis that was induced by  -VLDL plus fu-
coidan, or thapsigargin plus fucoidan, also was blocked in
Sra
 /  macrophages (unpublished data). Moreover, similar re-
sults were found using a blocking anti-SRA antibody with WT
macrophages, which also was effective at blocking 1,1 -dioc-
tadecyl-3,3,3 ,3 -tetramethylindocarbocyanine perchlorate (DiI)–
ac-LDL uptake (Fig. S5, A and B; available at http://www.jcb.org/
cgi/content/full/jcb.200502078/DC1). Thus, fucoidan and
CML-BSA induce apoptosis primarily through interaction with
the SRA. We also found that FC loading by ac-LDL plus 58035
was blocked completely in Sra
 /  macrophages, which con-
firmed that ac-LDL is taken up primarily through SRA (Fig. S5
C). Thus, the ability of ac-LDL (plus 58035) to induce apopto-
sis in macrophages can be explained by the ability of this lipo-
protein to both activate the UPR (i.e., by way of FC loading of
the cell) and engage the SRA.
To determine whether SRA deficiency prevented activa-
tion of p38 or induction of CHOP by CD-cholesterol, we as-
sayed these parameters in WT versus Sra
 /  macrophages. As
shown in Fig. S5, D–F, p38 phosphorylation, MK2 phosphory-
lation, and CHOP induction were similar in WT and Sra
 / 
macrophages under these conditions. Thus, FC-induced p38 ac-
tivation and CHOP induction occur independently of the SRA.
In the experiments described thus far, the SRA ligand
was added to the macrophages at the same time as the source of
cholesterol. To determine whether addition of the SRA ligand
after cholesterol loading could trigger apoptosis, macrophages
were loaded with CD-cholesterol (plus 58035) for 24 h, and
then treated with fucoidan for an additional 8 h. As shown in
Fig. 8 A, cells that were treated with CD-cholesterol for 24 h
and left untreated for an additional 8 h had very little induction
of apoptosis. However, when the cholesterol-loaded cells were
treated subsequently with fucoidan for 8 h, there was a marked
increase in apoptosis. As expected, cells that were treated with
CD-cholesterol plus fucoidan for the entire 32-h period had an
even greater induction of apoptosis. Similar results were ob-
tained using  -VLDL instead of CD-cholesterol (Fig. 8 B).
Apoptosis also was seen when the macrophages were incubated
with fucoidan, and then with  -VLDL plus 58035 (unpublished
data). Thus, engagement of the SRA before, or subsequent to,
cholesterol loading is able to induce apoptosis in FC-loaded,
UPR-activated macrophages.
Activation of JNK2 is necessary for 
UPR-SRA–dependent apoptosis in 
macrophages
Previous studies suggested roles for JNK in SRA-induced cy-
tokine production and SRA internalization (Hsu et al., 2001;
Ricci et al., 2004). Therefore, we considered the possibility that
JNK signaling played a role in SRA-dependent apoptosis in
UPR-activated macrophages. In this regard, we showed recently
that JNK is activated when macrophages are FC-loaded with ac-
LDL plus 58035 (Li et al., 2005). To test a possible role for JNK
in UPR-SRA–induced apoptosis, we first used the JNK inhibi-
tor SP600125 (Bennett et al., 2001). As shown in Fig. 9, A and B,
pretreatment of macrophages with SP600125 blocked apoptosis
that was induced by ac-LDL plus 58035 and by thapsigargin
plus fucoidan. To assess the specific role of JNK2, we used
Jnk2
 /  macrophages instead of the JNK inhibitor, and found a
similar inhibition of apoptosis (Fig. 9 C). Thus, JNK activation,
in general, and JNK2 activation, in particular, is necessary for
UPR-SRA–dependent apoptosis in macrophages.
Figure 7. Induction of apoptosis by fucoidan plus CD-cholesterol/58035
in macrophages requires SRA expression. WT and Sra
 /  macrophages
were left untreated or were incubated with CD-cholesterol (CD-Chol)/
58035 plus fucoidan (Fuc) for 18 h. The cells were stained with Alexa
488 Annexin V (green) and propidium iodide (red). Representative fluo-
rescent images are shown. Quantitative apoptosis data for each condition
are shown as described in the legend for Fig. 6. Data are expressed as
mean   SEM (n   4). Bar, 25  m.JCB • VOLUME 171 • NUMBER 1 • 2005 68
The original hypothesis was that JNK involvement would
be related to SRA signaling. However, additional experiments
revealed that JNK plays a role independent of the SRA. First,
thapsigargin alone induced JNK phosphorylation, which is
consistent with previous data in the literature (Li and Holbrook,
2004), and this effect was not augmented by fucoidan (Fig. 9 D).
Second, pretreatment of the cells with a blocking SRA anti-
body (2f8), which effectively inhibited DiI–ac-LDL uptake in
these cells (see Fig. S5 B), did not block JNK phosphorylation
(Fig. 9 E). Third, previous work in our laboratory showed that
cholesterol trafficking to the ER is necessary for JNK activation
(Li et al., 2005), which further suggests that JNK is activated by
ER cholesterol overload.
This last point raised an important issue—whether JNK
signaling was involved in the UPR–CHOP pathway. Previous
work showed that JNK activation was not downstream of
CHOP, because JNK was phosphorylated to the same extent in
FC-loaded Chop
 /  and Chop
 /  macrophages (Li et al., 2005).
To determine whether JNK was upstream of CHOP, FC-induced
CHOP expression was assayed in Jnk2
 /  macrophages. As
shown in Fig. 9 F, CHOP induction was the same in FC-loaded
WT and Jnk2
 /  macrophages. Similar results were observed
using the JNK inhibitor SB600125 (unpublished data). Thus,
JNK2 activation is necessary for UPR-SRA–dependent apoptosis
and, in the case of FC-loaded macrophages, is part of an ER-
cholesterol pathway that is independent of the CHOP branch of
the UPR.
In summary, the results of this study support a model in
which at least two other “hits” must conspire with the p38-
UPR-CHOP pathway to effect apoptosis in macrophages: en-
gagement of the SRA and activation of JNK2 (Fig. 10). These
hits can be activated by separate inducers, as depicted in the
figure, or by the same inducer, as is the case with ac-LDL.
Discussion
Studies of advanced atherosclerotic plaques in experimental an-
imals and humans showed a strong correlation between FC en-
richment, macrophage death, and lesional necrosis (Ball et al.,
1995; Ross, 1995; Libby et al., 1996; Mitchinson et al., 1996;
Kolodgie et al., 2000; Feng et al., 2003b). Lesional necrosis,
which is caused directly by macrophage death and likely results
from postapoptotic necrosis of these cells in the absence of pha-
gocytic clearance (Kockx, 1998), is believed to be a precipitat-
ing event in plaque rupture (Mitchinson et al., 1996). Plaque
rupture, in turn, leads to acute atherothrombotic vascular oc-
clusion and tissue infarction (Kolodgie et al., 2004). Thus,
elucidating the mechanisms of macrophage death in advanced
atherosclerotic lesions is an important step in understanding the
most critical stage of atherosclerotic vascular disease.
The connection between late lesional macrophage death
and FC enrichment has been suggested by several studies
(Small et al., 1984; Lundberg, 1985). Our recent work in this
area provided evidence for UPR activation and the necessity of
the UPR effector, CHOP, in FC-induced macrophage death
(Feng et al., 2003a). We have provided in vivo data suggesting
the importance of this pathway in advanced lesional necrosis,
and other groups also found evidence of UPR activation in ad-
vanced atherosclerotic lesions (Feng et al., 2003b; Austin et al.,
2004). Nonetheless, as we probed these processes further, it be-
came apparent that FC-induced UPR activation and apoptosis
were more complex than originally appreciated. In that context,
the work herein has revealed several critical steps in these
Figure 8. SRA engagement triggers apoptosis in macrophages that have
been FC loaded before exposure to SRA ligand. (A) Macrophages were incu-
bated with CD-cholesterol (CD-Chol)/58035 for 32 h. Some of the cells
received no fucoidan (Fuc), some received fucoidan (25  g/ml) at the
beginning of the incubation period, and some received fucoidan after 24 h
of incubation. (B) Macrophages were incubated with 10  g/ml  -VLDL plus
58035 for 24 h. Some of the cells received no fucoidan and some received
fucoidan after 16 h of incubation. For both sets of experiments, the cells
were stained with Alexa 488 Annexin V (green) and propidium iodide (red).
Representative fluorescent images are shown. Quantitative apoptosis data
for each condition are shown as described in the legend for Fig. 4. Data are
expressed as mean   SEM (n   4). Bar, 25  m.SRA AND MACROPHAGE APOPTOSIS • DEVRIES-SEIMON ET AL. 69
processes, depicted in Fig. 10. This new model has important
cell biologic and pathophysiologic implications.
Several new questions are raised by the findings in this
study. For example, future studies will need to address the up-
stream molecules in the MKK3–p38 and JNK pathways that
are stimulated by FC loading, and the downstream molecules
that lead to UPR activation and apoptosis. Typically, the
MKK3–p38 and JNK pathways are initiated by one of seve-
ral upstream kinases, including MEKK1–4, MLK2–3, DLK,
ASK1, Tpl2, and Tak1, that are activated by various forms of
cellular stress (Nishitoh et al., 2002; Roux and Blenis, 2004;
Kaneto et al., 2005). Examples of cellular stresses that are
known to activate these kinases are oxidative stress, inflamma-
tory cytokines, hypoxia/ischemia, and UV irradiation (Roux
and Blenis, 2004). Of relevance to the current study, p38 was
shown to be phosphorylated by ER stressors, such as tunicamy-
cin and thapsigargin (Hung et al., 2004; Li and Holbrook,
2004); however, the molecules that link ER stress to upstream
Figure 9. JNK2 is necessary for apoptosis, but activation is not dependent on SRA engagement. (A) Macrophages were preincubated for 30 min with
10  M SP600125 or with vehicle and then incubated for 18 h in medium alone or medium containing ac-LDL plus 58035   SP600125. The cells were
stained with Alexa 488 Annexin V (green) and propidium iodide (red). Representative fluorescent images and quantitative apoptosis data from four fields
of cells for each condition are shown. The data are expressed as the percent of total cells that stained with Annexin V and propidium iodide. Data are ex-
pressed as mean   SEM (n   4). Bar, 25  m. (B) Macrophages were preincubated for 30 min with 15  M SP600125 (SP) or with vehicle and then incu-
bated for 18 h in medium containing 25  g/ml fucoidan alone (Fuc), 0.5  M thapsigargin (Tg) alone, or both compounds. Quantitative apoptosis data
for each condition are shown as described in (A). Data are expressed as mean   SEM (n   4). (C) WT or Jnk2
 /  macrophages were incubated for 18 h in
medium alone or medium containing ac-LDL plus 58035, 0.5  M thapsigargin, or 0.5  M thapsigargin plus 25  g/ml fucoidan. Quantitative apoptosis
data for each condition are shown as described in (A). Data are expressed as mean   SEM (n   4). (D) Macrophages were incubated with 0.5  M
thapsigargin or 0.5  M thapsigargin plus 25  g/ml fucoidan for 0, 1, 2, and 3 h. Whole cell lysates were prepared as described in “Materials and
methods,” and were immunoblotted for activated phospho-Thr 
183/Tyr
185 JNK (phospho-JNK, top panel) and total JNK (bottom panel). (E) Macrophages
were preincubated for 30 min with medium alone or medium containing the anti-SRA antibody 2f8 or isotype control IgG2b (30  g/ml). The cells were in-
cubated for 3 h in medium alone or medium containing 0.5  M thapsigargin plus 25  g/ml fucoidan. Whole cell lysates were prepared as described in
“Materials and methods,” and were immunoblotted for activated phospho-Thr 
183/Tyr
185 JNK (top panel), and total JNK (bottom panel). (F) WT and Jnk2
 / 
macrophages (M s) were FC loaded for 0 or 12, and 15 h using 100  g/ml ac-LDL plus the ACAT inhibitor 58035. Whole cell lysates were prepared as
described in “Materials and methods,” and were immunoblotted for CHOP (top panel), total JNK (middle panel), and actin (bottom panel).JCB • VOLUME 171 • NUMBER 1 • 2005 70
activators of p38 have not been identified. JNK also was shown
to be activated by ER stress–in this case by an ASK1-dependent
mechanism (Nishitoh et al., 2002)—but further details in this
pathway remain to be elucidated. In FC-loaded macrophages,
sustained p38 phosphorylation and JNK phosphorylation were
inhibited by 70 nM U18666A, which selectively blocks choles-
terol trafficking to the ER (Feng et al., 2003a; Li et al., 2005).
However, p38 and JNK phosphorylation were not blocked in
Chop
 /  macrophages. These data raise the interesting possi-
bility that a non-CHOP branch of the UPR (e.g., the Ire1–XBP-1
branch) or an ER stress pathway, other than the UPR (e.g., the
PKR pathway [Gardner et al., 2005]), helps to initiate or sus-
tain p38 or JNK phosphorylation. The molecular basis of these
findings, as well as the downstream pathways linking p38 and
JNK to CHOP induction and apoptosis, will be the subject of
future studies.
One of the critical new issues raised by this study is the
mechanism by which SRA engagement triggers apoptosis in
FC-loaded/UPR-activated macrophages. Previous reports sug-
gested possible signaling effects of the SRA. Miki et al. (1996)
showed that incubation of THP-1 human macrophages with
ac-LDL induced tyrosine phosphorylation of several cellular
proteins. In particular, the tyrosine kinase, Lyn, was phosphor-
ylated and activated within 30 s of ac-LDL binding, and Lyn
was found to be associated with the SRA by immunoprecipita-
tion experiments. Hsu et al. (1998) found similar results using
lipoprotein and nonlipoprotein ligands of the SRA. In addition,
these investigators showed that PLC 1 and PI3-kinase were
phosphorylated, and that cellular PKC activity was increased by
SRA engagement. In this study, one of the downstream effects
of kinase activation was induction of urokinase-type plasmino-
gen activator (Hsu et al., 1998). However, studies by Kim et al.
(2003) showed that tyrosine phosphorylation of PI3-kinase was
not SRA dependent, but required CD-14. In a follow-up study,
SRA engagement in J774 murine macrophages was implicated
in signaling cascades involving the tyrosine kinase, Src, which
activated Rac1 and p21-activated kinase. These pathways acti-
vated JNK and p38 with subsequent induction of interleukin-1
(Hsu et al., 2001). Finally, a recent study by Ricci et al. (2004)
presented data that implicated JNK in the phosphorylation and
endocytic function of the SRA. Our data suggest that JNK acti-
vation is necessary for ER stress–SRA-dependent apoptosis,
but the role of JNK is in the ER-stress component, not the
SRA component. Future work will be directed at determining
whether these previously reported non-JNK SRA signaling
events, or others, are involved in the apoptosis-triggering effect
of SRA ligands in FC-loaded/UPR-activated macrophages.
On a more fundamental level, we will need to determine
whether SRA ligand internalization is needed for the effect, and
whether triggering is mediated by SRA alone or by the interaction
of SRA with another “signaling receptor.” This latter scenario
might occur by SRA-mediated recruitment of another receptor
upon engagement, or by multivalent binding of ligands to SRA
with one or more other receptors. In this regard, fucoidan and
CML-BSA are known to interact with other receptors.
The multiple-hit model of apoptosis described here has po-
tentially important cell biologic implications related to ER stress.
Our current view is that ER stress strikes a delicate balance be-
tween survival and apoptosis, which, in the absence of other
“hits,” favors survival. Cell survival in the initial stages of ER
stress is likely necessary to give repair processes a chance to
work. For example, one or more effectors downstream of PERK
activation are involved in cell survival, because genetic defi-
ciency of PERK markedly accelerates cell death, including that
induced by FC loading (Feng et al., 2003a). Conversely, ER-
stressed cells need to be prepared to undergo apoptosis if the
Figure 10. Model of how ER stress, MAPK pathways, and SRA engagement conspire to induce apoptosis in FC-loaded macrophages. Excess FC loading
of the ER induces an ER stress response that leads to activation of p38 and JNK. Activation of p38, in turn, induces the UPR effector, CHOP. Three
pathways—p38-CHOP, JNK, and engagement of the SRA—combine to induce apoptosis. Ac-LDL is able to trigger all three pathways, because it delivers
cholesterol to the cells and is a ligand for the SRA.SRA AND MACROPHAGE APOPTOSIS • DEVRIES-SEIMON ET AL. 71
repair processes do not succeed (Kadowaki et al., 2004). Thus,
ER stress induces several anti- and proapoptotic processes that
keep the cells alive for a while, but enable rapid onset of apopto-
sis when needed. In this context, FC/UPR-activated macro-
phages may be balanced in favor of cell survival; engagement of
the SRA might tip the balance toward apoptosis by inhibiting
one or more of the survival mechanisms and/or by inducing
additional proapoptotic mechanisms.
The major SRA-ligand lipoprotein in atherosclerotic le-
sions is oxidized low density lipoprotein (LDL), but this lipopro-
tein has complex effects on macrophage viability. For example,
at low concentrations, oxidized LDL promotes macrophage
survival by induction of the Akt pathway (Hundal et al., 2001).
Although higher concentrations of oxidized LDL do induce
apoptosis (Wintergerst et al., 2000), it is questionable whether
these high levels exist in lesions. Moreover, antioxidant trials
in humans failed to show beneficial effects on coronary artery
disease (Meagher and Rader, 2001). Conversely, advanced ath-
erosclerotic lesions have massive amounts of non-SRA–ligand
lipoproteins that are very effective at loading macrophages
with cholesterol, such as remnant lipoproteins (which is mod-
eled by  -VLDL) and aggregated lipoproteins (Hoff and Mor-
ton, 1985; Guyton and Klemp, 1996). Moreover, these lesions
also have abundant molecules that can bind to the SRA, such as
matrix proteins. Of particular interest is the finding that ele-
vated levels of advanced glycosylation end-products (AGEs)
and advanced lipoxidation end-products (Baynes and Thorpe,
2000) are found in diabetic and nondiabetic patients who have
coronary artery disease (Kilhovd et al., 1999). Immunohis-
tochemical analysis of human atherosclerotic lesions demon-
strated AGE deposition extracellularly and intracellularly in
macrophages (Nakamura et al., 1993). The function of AGEs
as apoptosis triggers may be particular relevant given the high
incidence of vulnerable plaque formation and atherothrombotic
vascular disease in diabetes.
In summary, the data herein shed new light on the funda-
mental issue of how ER stress leads to apoptosis and on how the
UPR, MAPKs, and the SRA might conspire to cause macro-
phage apoptosis, lesional necrosis, and plaque instability in ad-
vanced atherosclerosis. These findings will help in the design of
future mechanistic and in vivo studies to elucidate further the
cell biologic and pathophysiologic implications of this work.
Materials and methods
Materials
Falcon tissue culture plastic and 11-mm coverslips were purchased from
Fisher Scientific. Tissue culture media, cell culture reagents, and heat-inac-
tivated FBS (GIBCO BRL) were purchased from Invitrogen. The acyl-coen-
zyme A-cholesterol acyltransferase (ACAT) inhibitor 58035 (3-[decyldi-
methylsilyl]-N-[2-(4-methylphenyl)-1-phenylethyl]propanamide (Ross et al.,
1984) was from J. Heider, formally of Sandoz (East Hanover, NJ). A 10-
mg/ml stock was made in DMSO and used at a concentration of 10  g/ml
in all experiments. All other chemical reagents, including tunicamycin,
thapsigargin, methyl- -cyclodextrin (CD), cholesterol-oleate, concanavalin
A, and fucoidan, were purchased from Sigma-Aldrich. Methyl- -CD was
saturated with cholesterol as previously described (Christian et al., 1997).
The mouse monoclonal antibodies against GADD 153 (CHOP) and tubu-
lin were purchased from Santa Cruz Biotechnology, Inc. Antibodies
against p38 MAPK, phospho-(Thr180/Tyr182) p38 MAPK, phospho-
(Thr334) MAPKAPK-2, MAPKAPK-2, phospho-(Thr183/Tyr185) c-Jun
NH2-terminal kinase (JNK)1/2, and JNK1/2 were purchased from Cell
Signaling Technology. The mouse monoclonal antibody to actin was pur-
chased from CHEMICON International. Antibody 2f8 directed against the
type A scavenger receptor (SRA) and isotype control antibodies were pur-
chased from Serotec. The HRP-conjugated donkey anti–mouse and donkey
anti–rabbit IgG secondary antibodies were purchased from Jackson Immu-
noResearch Laboratories. The compound SP600125 was purchased from
Biosource International. The Vybrant Annexin V/Propidium Iodide Apopto-
sis Assay kit #2 was from Molecular Probes. Carboxymethyllysine-modi-
fied (CML)-BSA (24.5% lysine residues modified as CML) and control BSA
( 0.5% lysine modified as CML) were provided by S. Thorp (University of
South Carolina, Columbia, SC) (Reddy et al., 1995). DiI–acetyl LDL was
purchased from Molecular Probes.
Mice
Mkk3
 /  mice on a C57BL/6J background were generated as described
previously (Wysk et al., 1999). Chop
 /  mice on a C57BL/6J back-
ground were provided by D. Ron (New York University, New York, NY)
(Zinszner et al., 1998) and R. Burke (Columbia University, New York,
NY). Female Balb/c and C57BL6J mice were purchased from The Jackson
Laboratory. Female Mapkapk
 /  (Mk2
 / ) mice, reported previously by
Kotlyarov et al. (1999), were provided by Y. Wang (UCLA, Los Angeles,
California). Sra
 /  (Msr
 / ) mice on the C57BL/6J background were gen-
erated as described previously (Sakai et al., 1996). Macrophages from
female 8–10-wk-old C57BL/6J mice were used as wild-type (WT) controls
in most experiments. Jnk2
 /  mice on the C57BL/6J background were
generated as described previously (Yang et al., 1998). Macrophages de-
ficient in p38 were obtained from p38
flox/flox mice (Engel et al., 2005)
crossed with LysMCre/C57BL6 mice (Clausen et al., 1999).
Preparation of lipoproteins and CD-cholesterol
Low density lipoprotein (d, 1.020–1.063 g/ml) from fresh human plasma
was isolated by ultracentrifugation (Havel et al., 1955). Acetylated-LDL
(ac-LDL) was prepared from a reaction with acetic anhydride as described
previously (Basu et al., 1976), and used at a concentration of 100  g/ml
in all experiments.  -Very low density lipoprotein (VLDL) was isolated from
a New Zealand white rabbit that was fed a 2% cholesterol diet for 3 wk
and fasted the night before phlebotomy (Tabas et al., 1990). CD-choles-
terol was prepared as described (Feng et al., 2003a).
FC loading of mouse peritoneal macrophages
Peritoneal macrophages from adult female C57BL6J mice—and all mutant
mice used in this study—were harvested 3 d after i.p. injection of conca-
navalin A (Feng et al., 2003a), or 4 d after i.p. injection of methyl-BSA
(mBSA) in mice that were immunized previously with this antigen (Cook et
al., 2003). For the latter method, 2 mg/ml mBSA in 0.9% saline was
emulsified in an equal volume of Complete Freund’s adjuvant (CFA;
DIFCO). Mice were immunized intradermally with 100  l emulsion. 14 d
later, the immunization protocol was repeated, except incomplete
Freund’s adjuvant was used instead of CFA. 7 d later, the mice were in-
jected i.p. with 0.5 ml PBS containing 100  g mBSA. Macrophages were
harvested 4 d later by peritoneal lavage. All macrophages were grown in
full medium containing DME, 10% FBS, and 20% L-cell conditioned me-
dium. The medium was replaced every 24 h until cells reached 90% con-
fluency. On the day of the experiment, the cells were washed three times
in warm PBS and incubated as described in each figure legend. WT and
mutant macrophages were FC-loaded by incubation with full medium con-
taining 10  g/ml of the ACAT inhibitor 58035 plus 100  l/ml of ac-LDL,
5 mM methyl- -CD/cholesterol (5:1 mass ratio), or 10–50  g/ml  -VLDL.
Cells were labeled with DiI–ac-LDL at 10  g/ml in DME/0.02% BSA at
37 C for 60 min. Cells were washed with PBS and incubated with 2% PFA
in medium for 10 min, washed, and viewed by fluorescent microscopy as
described below.
Cell death assays
After FC loading, macrophages were assayed for early- to mid-stage
apoptosis by staining with Alexa 488–conjugated Annexin V (green), and
for late-stage apoptosis by costaining with propidium iodide (red), as de-
scribed previously (Yao and Tabas, 2000). Cells were viewed immedi-
ately at room temperature using an Olympus IX-70 inverted fluorescent
microscope equipped with a mercury 100W lamp (CHIU Tech. Corp.), fil-
ter wheels, fluorescent filters (Chroma Technology Corp.), an Olympus
LCPlanF1 20  objective, Imaging software (Roper Scientific), and a Cool
Snap CCD camera (RS Photometrics). Representative fields (4–6 fields
containing  1,000 cells) were photographed for each condition. The num-
ber of Annexin V/propidium iodide–positive were counted and expressedJCB • VOLUME 171 • NUMBER 1 • 2005 72
as a percent of the total number of cells in at least four separate fields from
duplicate wells.
Whole-cell cholesterol esterification assay
Macrophages were incubated for 5 h with ac-LDL or 18 h with CD-choles-
terol, all in the presence of 0.1 mM 
14C-labeled oleate; esterification was
assayed as described (Tabas et al., 1987).
Immunoblot analysis
Cells were lysed in a buffer containing 2% SDS, 62.5 mM Tris-HCl (pH
6.8), 10% glycerol, 50 mM DTT, and 0.01% bromophenol blue, and were
boiled at 100 C for 5 min. Cytosolic and nuclear extracts were isolated us-
ing the Nuclear Extraction Kit (PANOMIC) according to the manufacturer’s
protocol. Approximately 100  g lysate protein was separated on a 4–20%
gradient SDS-PAGE gel (Invitrogen), and electrotransferred to 0.45- m ni-
trocellulose membrane using a Bio-Rad Laboratories mini-transfer tank.
Membranes were incubated with primary antibodies overnight, and the
protein bands were detected with HRP-conjugated secondary antibodies
and SuperSignal West Pico enhanced chemiluminescent solution (Pierce
Chemical Co.). Membranes were stripped with Restore Western Blot Strip-
ping Buffer (Pierce Chemical Co.) for 15 min at room temperature, and re-
probed with antibodies to actin to control for differences in loading.
Statistics
Values are given as means   SEM; no error bars in the bar graphs signify
that SEM values were smaller than the graphic symbols.
Online supplemental material
Fig. S1 shows that CHOP induction by FC loading is blocked in macro-
phages deficient in p38 MAPK. Fig. S2 shows that apoptosis is blocked in
macrophages deficient in MK2. Fig. S3 shows that p38 MAPK is necessary
for CHOP induction by  -VLDL. Fig. S4 shows that CHOP is necessary for in-
duction of apoptosis by fucoidan. Fig. S5 shows that induction of apoptosis
by ac-LDL plus 58035, fucoidan, or CML-BSA in cholesterol-enriched mac-
rophages is mediated by the SRA. Online supplemental material available
at http://www.jcb.org/cgi/content/full/jcb.200502078/DC1.
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